Control of graft-versus-host disease with maintenance of the graft-versus-leukemia effect in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes-Reference-Cited by-同舟云学术

Control of graft-versus-host disease with maintenance of the graft-versus-leukemia effect in a murine allogeneic transplant model using retrovirally transduced murine suicidal lymphocytes

Published:2007-05 Issue:5 Volume:35 Page:842-853
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Kornblau Steven M.,Aycox Preston G.,Stephens L. Clifton,McCue David,Champlin Richard E.,Marini Frank C.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference42 articles.

1. Bone marrow transplants may cure patients with acute leukemia never achieving remission with chemotherapy;Biggs;Blood,1992

2. Graft-versus-host-disease;Sullivan,1999

3. T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease;Papadopoulos;Blood,1998

4. Sturm und drang over suicidal lymphocytes;Sadelain;Mol Ther,2002

5. HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia;Bonini;Science,1997

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic Pathways in Alloreactive T Cells;Frontiers in Immunology;2020-07-24

2. Imaging of Sleeping Beauty-Modified CD19-Specific T Cells Expressing HSV1-Thymidine Kinase by Positron Emission Tomography;Molecular Imaging and Biology;2016-05-31

3. Donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene: detailed immunological function following add-back after haplo-identical transplantation;Cytotherapy;2015-12

4. Graft-versus-leukemia Effect of HLA-haploidentical Central-memory T-cells Expanded With Leukemic APCs and Modified With a Suicide Gene;Molecular Therapy;2013-02

5. T cell gene-engineering to enhance GVT and suppress GVHD;Best Practice & Research Clinical Haematology;2011-09